Pfizer strikes gene therapy deal with Sangamo
Says one of the candidates included has best-in-class potential - News - PharmaTimes
by PharmaTimes reporter
www.pharmatimes.com/news/pfizer_strikes_gene_therapy_deal_with_sangamo_1192766
Search results
Found 150 pages
AUTHOR: PharmaTimes reporter
Alzheimer’s research seeing 'exceptionally high levels' of innovation
Nearly two-thirds of pipeline products have first-in-class potential - News - PharmaTimes
by PharmaTimes reporter
www.pharmatimes.com/news/alzheimers_research_seeing_exceptionally_high_levels_of_innovation_1193028Takeda establishes new drug discovery subsidiary
Also transfers part of its pharmaceutical sciences businesses to Bushu - News - PharmaTimes
by PharmaTimes reporter
www.pharmatimes.com/news/takeda_establishes_new_drug_discovery_subsidiary_1192847Video surveillance could support dementia patients
But consent would be key for the use of home camera-based systems - News - PharmaTimes
by PharmaTimes reporter
www.pharmatimes.com/news/video_surveillance_could_support_dementia_patients_1193020Risk specialists arrested in China
A husband and wife corporate investigation team that have reportedly worked for GlaxoSmithKline have been arrested in China. - News - PharmaTimes
by PharmaTimes reporter
www.pharmatimes.com/news/risk_specialists_arrested_in_china_1005582Gilead-backed Hep B vaccine fails
GlobeImmune and partner Gilead suffered a setback this week after its new hepatitis B vaccine GS-4774 missed its mid-stage trial target. - News - PharmaTimes
by PharmaTimes Reporter
www.pharmatimes.com/news/gilead-backed_hep_b_vaccine_fails_971449FDA approves Salix and Actavis IBS drugs
Two new treatments for irritable bowel syndrome (IBS) have been approved by the US Food and Drug Administration. - News - PharmaTimes
by PharmaTimes Reporter
www.pharmatimes.com/news/fda_approves_salix_and_actavis_ibs_drugs_971451UK life sciences financing on the up
There has been a resurgence in life sciences financing in the UK, amounting to $2.86 billion, new figures reveal. - News - PharmaTimes
by PharmaTimes Reporter
www.pharmatimes.com/news/uk_life_sciences_financing_on_the_up_971188Talent awarded in life sciences
Talent and skills have been recognised at the second UK Life Science Skills Awards. - News - PharmaTimes
by PharmaTimes reporter
www.pharmatimes.com/news/talent_awarded_in_life_sciences_1001956Eisai rolls out Fycompa real world data
A raft of real world data for Eisai’s Fycompa has been presented at this week’s European Congress on Epileptology in Stockholm. - News - PharmaTimes
by PharmaTimes reporter
www.pharmatimes.com/news/eisai_rolls_out_fycompa_real_world_data_1002140
